Atlas Trials

A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Clinical trial NCT07145151 · RECRUITING

Trial details

NCT number
NCT07145151
Sponsor
The United Bio-Technology (Hengqin) Co., Ltd.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metabolic Dysfunction-associated Steatohepatitis (MASH)
Start date
2025-09-30
Primary completion
2027-06-04
Enrollment
156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.